Search

Medpace Holdings Inc

Закрыт

СекторЗдравоохранение

584.94 0.72

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

577.01

Макс.

594.74

Ключевые показатели

By Trading Economics

Доход

-2.5M

121M

Продажи

727K

707M

P/E

Средняя по отрасли

34.721

56.597

Прибыль на акцию

4.25

Рентабельность продаж

17.158

Сотрудники

6,500

EBITDA

-21M

134M

Дивиденды

By Acuity

Следующий отчет о доходах

21 окт. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.4B

17B

Предыдущая цена открытия

584.22

Предыдущая цена закрытия

584.94

Новостные настроения

By Acuity

50%

50%

136 / 339 Рейтинг в Healthcare

Medpace Holdings Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 сент. 2026 г., 20:08 UTC

Medpace Holdings Inc. is advancing during Friday's session, having reached a session high earlier, though it has since pulled back from that peak.

3 сент. 2026 г., 20:07 UTC

News

Medpace Holdings shares are declining amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2 сент. 2026 г., 20:08 UTC

Medpace Holdings Inc. is rising amid broader gains in the Life Sciences Tools & Services sector, despite no specific company news driving the movement.

1 сент. 2026 г., 20:08 UTC

Correlated Moves
News

Medpace Holdings Inc shares are lower amid insider selling and an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing.

31 авг. 2026 г., 20:07 UTC

Correlated Moves

Medpace Holdings shares are lower today, reflecting broader sector dynamics and rising interest rate expectations following the Jackson Hole Economic Symposium.

26 авг. 2026 г., 20:08 UTC

Medpace Holdings Inc. shares are higher today, continuing an upward trend since Tuesday's close. The stock remains above its 20-day moving average.

25 авг. 2026 г., 20:07 UTC

News

Shares of Medpace Holdings Inc are trading lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing by company officers.

20 авг. 2026 г., 19:41 UTC

Social Media

Medpace Holdings Inc. is rising amid strong gains in the Life Sciences Tools & Services sector and positive sentiment surrounding biotech investments.

19 авг. 2026 г., 20:02 UTC

Medpace Holdings Inc. shares are higher, driven by a significant advance in the Life Sciences Tools & Services sub-sector amid a strong market session.

17 авг. 2026 г., 20:02 UTC

News

Medpace Holdings Inc. shares are higher following a Barron's report suggesting significant upside potential and robust Q2 results exceeding analyst expectations.

14 авг. 2026 г., 19:36 UTC

Medpace Holdings Inc shares are lower amid broader market sentiment following a Commerce Department report showing a decline in retail sales for July.

13 авг. 2026 г., 19:56 UTC

News

Medpace Holdings shares are lower as CEO August J. Troendle sold 23,144 shares valued at $13.98 million, raising investor concerns about future performance.

7 авг. 2026 г., 19:16 UTC

Medpace Holdings Inc. shares are lower today, reflecting a slight pullback amid broader market factors, including economic signals and geopolitical tensions.

3 авг. 2026 г., 19:26 UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

30 июл. 2026 г., 19:22 UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

29 июл. 2026 г., 18:44 UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

28 июл. 2026 г., 23:11 UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

27 июл. 2026 г., 16:56 UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24 июл. 2026 г., 18:26 UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22 июл. 2026 г., 23:22 UTC

Social Media
News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21 июл. 2026 г., 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Сравнение c конкурентами

Изменение цены

Medpace Holdings Inc Прогноз

Консенсус по рейтингу

By TipRanks

Нейтрально

11 ratings

2

Покупка

9

Удержание

0

Продажа

Настроения

By Acuity

136 / 339Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat